Further to DrugAlert vol 998, HPS Pharmacies wish to advise that Juno Pharmaceuticals is continuing to experience a supply interruption for Amiodarone Juno ampoules as follows:
Amiodarone Juno Ampoules
Amiodarone hydrochloride 150mg/3mL
ARTG 233673
This supply interruption is anticipated to continue until late June 2025.
The Therapeutic Goods Administration (TGA) has now authorised the supply of a Section 19A alternative. This product is registered in the UK and all labelling is in English.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates